RBL2 and breast carcinoma: Several basal B type breast cancers, such as HCC150082 and Cal-5183, harbour RBL2 loss of heterozygosity (LOH) mutations induced by a frameshift in the gene product and have reduced expression of RBL2 protein (Supplementary Fig. 9l).